Mintek Pacemaker LV-T Instrukcja Użytkownika Pobierz pdf (Strona 32)

24 Stratos LV/LV-T Technical Manual

Table 1: Patient Demographics at Enrollment

Characteristic Group1 Group 2 Group 3

P-value

Other Medical

History

Diabetes

Chronic Lung

Disease

Thyroid Disease

Chronic Kidney

Disease

Prior Ischemic

Stroke or TIA

Prior Embolic

Events

(non-

cerebrovascular)

N=29

13 (44.8%)

7 (24.1%)

12 (41.4%)

4 (13.8%)

7 (24.1%)

1 (2.3%)

N=36

9 (25.0%)

16 (44.4%)

12 (33.3%)

5 (13.9%)

10 (27.8%)

3 (6.0%)

N=17

4 (23.5%)

7 (41.2%)

5 (29.4%)

1 (5.9%)

6 (35.3%)

2 (8.0%)

0.287**

0.211**

0.791**

0.836**

0.726**

0.653**

*One-way ANOVA, ** Chi-Square test (2-sided)

Table 2 provides a summary of the AF medical history. Table 3

provides a summary of cardiac medications patients were taking

at the time of enrollment. Please note some categories may

equal more than 100% as several categories allow more than

one response. In some cases, complete demographic data was

not provided for all patients. There were no statistical

differences in AF medical history and cardiac medication at

enrollment between the 3 groups.

1 2 ... 27 28 29 30 31 32 33 34 35 36 37 ... 171 172

Komentarze do niniejszej Instrukcji

Brak uwag

Mintek Pacemaker LV-T Instrukcja Użytkownika Strona 32

Komentarze do niniejszej Instrukcji